Fluorescent and biotinylated probes for B2 bradykinin receptors:: Agonists and antagonists

被引:2
作者
Howl, J [1 ]
机构
[1] Wolverhampton Univ, Sch Hlth Sci, Mol Pharmacol Grp, Wolverhampton WV1 1DJ, W Midlands, England
关键词
bradykinin; receptor; biotin; aminomethyl coumarin; ligand binding;
D O I
10.1016/S0196-9781(99)00033-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Peptide ligands carrying additional reporter groups are valuable research tools to facilitate biochemical and pharmacological studies of G protein-coupled receptors. B-2 bradykinin receptors, widely distributed in mammalian tissues, regulate many physiological systems and are therapeutic targets. Acylation of the amino-terminus of bradykinin (BK) and a B-2a-selective antagonist produced ligands derivatized with biotinamidocaproate or 7-Amino-4-methylcoumarin-3-acetate. These fluorescent and biotinylated peptides bound with high affinity to bovine and rodent B-2 receptors. Analysis of second messenger production confirmed that fluorescent and biotinylated analogs of BK were B-2 receptor agonists whereas derivatives of DArg(0)[Hyp(3),DPhe(7),Leu(8)]BK were BK receptor antagonists. The complimentary properties of these selective receptor probes will be useful in studying B-2 receptor localization, expression and desensitization. (C) 1999 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:515 / 518
页数:4
相关论文
共 26 条
[1]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[2]  
FARMER SG, 1990, ANN REV PHARM TOXICO, V32, P511
[3]  
HOCK FJ, 1991, BRIT J PHARMACOL, V102, P769, DOI 10.1111/j.1476-5381.1991.tb12248.x
[4]   FLUORESCENT AND BIOTINYLATED LINEAR PEPTIDES AS SELECTIVE BIFUNCTIONAL LIGANDS FOR THE V1A VASOPRESSIN RECEPTOR [J].
HOWL, J ;
WANG, XG ;
KIRK, CJ ;
WHEATLEY, M .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 213 (02) :711-719
[5]   Renal bradykinin and vasopressin receptors: Ligand selectivity and classification [J].
Howl, J ;
Yarwood, NJ ;
Davies, ARL ;
Wheatley, M .
KIDNEY INTERNATIONAL, 1996, 50 (02) :586-592
[6]   Chimeric strategies for the rational design of bioactive analogs of small peptide hormones [J].
Howl, J ;
Langel, U ;
Hawtin, SR ;
Valkna, A ;
Yarwood, NJ ;
Saar, K ;
Wheatley, M .
FASEB JOURNAL, 1997, 11 (07) :582-590
[7]  
HOWL J, 1993, METHODS NEUROSCI, V13, P281
[8]   Bradykinin enhances GLUT4 translocation through the increase of insulin receptor tyrosine kinase in primary adipocytes: Evidence that bradykinin stimulates the insulin signalling pathway [J].
Isami, S ;
Kishikawa, H ;
Araki, E ;
Uehara, M ;
Kaneko, K ;
Shirotani, T ;
Todaka, M ;
Ura, S ;
Motoyoshi, S ;
Matsumoto, K ;
Miyamura, N ;
Shichiri, M .
DIABETOLOGIA, 1996, 39 (04) :412-420
[9]   RECEPTOR COUPLED EVENTS IN BRADYKININ ACTION - RAPID PRODUCTION OF INOSITOL PHOSPHATES AND REGULATION OF CYTOSOLIC FREE CA-2+ IN A NEURAL CELL-LINE [J].
JACKSON, TR ;
HALLAM, TJ ;
DOWNES, CP ;
HANLEY, MR .
EMBO JOURNAL, 1987, 6 (01) :49-54
[10]   A PROPOSED MODEL OF BRADYKININ BOUND TO THE RAT B2 RECEPTOR AND ITS UTILITY FOR DRUG DESIGN [J].
KYLE, DJ ;
CHAKRAVARTY, S ;
SINSKO, JA ;
STORMANN, TM .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (09) :1347-1354